NCT03704220View on ClinicalTrials.gov

Anti-thrombotic Monotherapy With the HeartMate 3 LVAS

NAUnknownINTERVENTIONAL

Enrollment

10

Participants

Timeline

Start Date

August 16, 2018

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions

Heart FailureCardiovascular Diseases

Interventions

DRUG

Warfarin

Removal of anticoagulation with warfarin

Trial Locations (1)

14021

Institute for Clinical and Experimental Medicine, Prague

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Abbott

INDUSTRY

lead

Institute for Clinical and Experimental Medicine

OTHER_GOV

NCT03704220 - Anti-thrombotic Monotherapy With the HeartMate 3 LVAS | Biotech Hunter | Biotech Hunter